Ro CEO Zach Reitano: The case for GLP-1s | Rapid Response

About Zach

• Founder and CEO of Ro; built nationwide telemedicine, pharmacy and labs platform
  
• Grew Ro from 1-condition telehealth start-up to care for millions since 2017
  
• Ro valued at $7B in 2024 amid the GLP-1 boom
  
• Named to Fortune 40 Under 40
  
• Also honored by Forbes 30 Under 30, Inc. 30 Under 30, BI 30 Under 40